WERFF, ten Bosch Jutte van der, Eva HLAVÁČKOVÁ, Charlotte DERPOORTER, Ute FISCHER, Francesco SAETTINI, Sujal GHOSH, Roula FARAH, Delfien BOGAERT, Rabea WAGENER, Jan LOEFFEN, Chris M BACON and Simon BOMKEN. How to recognize inborn errors of immunity in a child presenting with a malignancy: guidelines for the pediatric hemato-oncologist. Pediatric Hematology and Oncology. Philadelphia: Taylor & Francis, 2023, vol. 40, No 2, p. 131-146. ISSN 0888-0018. Available from: https://dx.doi.org/10.1080/08880018.2022.2085830.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name How to recognize inborn errors of immunity in a child presenting with a malignancy: guidelines for the pediatric hemato-oncologist
Authors WERFF, ten Bosch Jutte van der (guarantor), Eva HLAVÁČKOVÁ (203 Czech Republic, belonging to the institution), Charlotte DERPOORTER, Ute FISCHER, Francesco SAETTINI, Sujal GHOSH, Roula FARAH, Delfien BOGAERT, Rabea WAGENER, Jan LOEFFEN, Chris M BACON and Simon BOMKEN.
Edition Pediatric Hematology and Oncology, Philadelphia, Taylor & Francis, 2023, 0888-0018.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30204 Oncology
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 1.700 in 2022
RIV identification code RIV/00216224:14110/23:00130254
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1080/08880018.2022.2085830
UT WoS 000834935100001
Keywords in English Inborn errors of immunity; investigation; malignancy; pediatric; primary immunodeficiency
Tags 14110114, 14110321, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 24/2/2023 09:22.
Abstract
Inborn errors of immunity (IEI) are a group of disorders caused by genetically determined defects in the immune system, leading to infections, autoimmunity, autoinflammation and an increased risk of malignancy. In some cases, a malignancy might be the first sign of an underlying IEI. As therapeutic strategies might be different in these patients, recognition of the underlying IEI by the pediatric hemato-oncologist is important. This article, written by a group of experts in pediatric immunology, hemato-oncology, pathology and genetics, aims to provide guidelines for pediatric hemato-oncologists on how to recognize a possible underlying IEI and what diagnostic tests can be performed, and gives some consideration to treatment possibilities.
PrintDisplayed: 13/7/2024 13:11